As Gianakakos, Chief Medical Officer Edelberg and the rest of the Kardigan team continue developing their pipeline through ...

With cardiovascular disease remaining the leading cause of death in the United States, this Heart Month (February), FIU is ...

Cardiovascular disease remains the leading global killer. Still, too many late-stage cardiology trials stumble, not for lack of biology, but because episodic, clinic-bound measures miss what matters ...

Please provide your email address to receive an email when new articles are posted on . Women are historically underrepresented in cardiovascular trials. Recent trials on acute coronary syndrome, ...

Despite long-standing inclusivity requirements, women largely remain underrepresented in clinical cardiology trials, according to a report published Aug. 9 in the Journal of the American College of ...

Women represent 41% of participants in clinical trials investigating cardiovascular health and disease, according to a study published Aug. 31 in JAMA Network Open. Led by researchers from Los Angeles ...

TUESDAY, Sept. 16, 2025 (HealthDay News) -- In recent years, challenges have persisted in representation of women within cardiovascular (CV) clinical trials, according to a study published online Aug.

MANCHESTER — Two ongoing cardiology trials in the UK are facing substantial recruitment challenges, researchers reported at the British Cardiovascular Society (BCS) Annual Conference 2025. The BRITISH ...

Women are underrepresented in cardiovascular trials, especially in arrhythmia, CHD, ACS, and heart failure studies, as shown by low participation:prevalence ratios. Trials in pulmonary hypertension ...